106 related articles for article (PubMed ID: 11081260)
21. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
22. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
23. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
24. Isolated porta hepatis metastasis of papillary thyroid cancer.
Bakheet SM; Powe J; Hammami MM; Amin TM; Akhtar M; Ahmed M
J Nucl Med; 1996 Jun; 37(6):993-4. PubMed ID: 8683330
[TBL] [Abstract][Full Text] [Related]
25. Multiple subdermal metastases from papillary thyroid cancer.
Luo QY; Luo Q; Chen LB; Yu YL; Lu HK; Zhu RS
Thyroid; 2008 Aug; 18(8):907-8. PubMed ID: 18690798
[No Abstract] [Full Text] [Related]
26. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
27. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
28. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
[TBL] [Abstract][Full Text] [Related]
29. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma.
Matheja P; Lerch H; Schmid KW; Kuwert T; Schober O
J Nucl Med; 1997 Jul; 38(7):1022-4. PubMed ID: 9225783
[TBL] [Abstract][Full Text] [Related]
30. [Somatostatin receptor status in non-medullary thyroid carcinoma].
Görges R; Kahaly G; Müller-Brand J; Mäcke H; Walgenbach S; Bruns C; Andreas J; Brandt-Mainz K; Bockisch A
Nuklearmedizin; 1999; 38(1):15-23. PubMed ID: 9987777
[TBL] [Abstract][Full Text] [Related]
31. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
33. False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid Cancer.
Tong J; Jin Y; Liu M; Lv Z; Chen L
Clin Nucl Med; 2018 May; 43(5):375-376. PubMed ID: 29517545
[TBL] [Abstract][Full Text] [Related]
34. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
[TBL] [Abstract][Full Text] [Related]
35. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
36. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Joensuu H; Ahonen A
J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
[TBL] [Abstract][Full Text] [Related]
37. Renal metastases from papillary thyroid carcinoma.
Sardi A; Agnone CM; Pellegrini A
J La State Med Soc; 1992 Sep; 144(9):416-20. PubMed ID: 1402321
[TBL] [Abstract][Full Text] [Related]
38. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
Tonami N; Hisada K
Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
[TBL] [Abstract][Full Text] [Related]
39. Benign epithelial cyst mimicking thyroid cancer metastasis: a false-positive finding on post-therapy I-131 scan.
Bural GG; Peel RL; Mountz JM
Clin Nucl Med; 2012 Jan; 37(1):88-90. PubMed ID: 22157038
[No Abstract] [Full Text] [Related]
40. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]